HJ, H., OA, K., II, V., PA, T., & S, H. (2020). Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches. Dove Medical Press.
Cita Chicago Style (17a ed.)HJ, Huang, Kraevaya OA, Voronov II, Troshin PA, y Hsu S. Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches. Dove Medical Press, 2020.
Cita MLA (8a ed.)HJ, Huang, et al. Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches. Dove Medical Press, 2020.
Precaución: Estas citas no son 100% exactas.